The gut-liver axis in immune remodeling of hepatic cirrhosis

被引:22
作者
Guan, Huayu [1 ,2 ]
Zhang, Xiang [1 ]
Kuang, Ming [2 ]
Yu, Jun [1 ]
机构
[1] Chinese Univ Hong Kong, Inst Digest Dis, Dept Med & Therapeut, State Key Lab Digest Dis, Hong Kong, Peoples R China
[2] Sun Yat Sen Univ, Affiliated Hosp 1, Ctr Hepatopancreatobiliary Surg, Dept Liver Surg, Guangzhou, Peoples R China
关键词
gut-liver axis; microbiota; immune; gut microbiome; liver cirrhosis; immune homeostasis; immune remodeling; INTESTINAL BACTERIAL OVERGROWTH; UNFOLDED PROTEIN RESPONSE; VASCULAR BARRIER; CELL-FUNCTION; T-CELLS; INFLAMMATION; TRANSLOCATION; MICROBIOME; INFECTION; FIBROSIS;
D O I
10.3389/fimmu.2022.946628
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In healthy settings, the gut-liver axis allows host-microbiota communications and mediates immune homeostasis through bidirectional regulation. Meanwhile, in diseases, gut dysbiosis, combined with an impaired intestinal barrier, introduces pathogens and their toxic metabolites into the system, causing massive immune alternations in the liver and other extrahepatic organs. Accumulating evidence suggests that these immune changes are associated with the progression of many liver diseases, especially hepatic cirrhosis. Pathogen-associated molecular patterns that originated from gut microbes directly stimulate hepatocytes and liver immune cells through different pattern recognition receptors, a process further facilitated by damage-associated molecular patterns released from injured hepatocytes. Hepatic stellate cells, along with other immune cells, contribute to this proinflammatory and profibrogenic transformation. Moreover, cirrhosis-associated immune dysfunction, an imbalanced immune status characterized by systemic inflammation and immune deficiency, is linked to gut dysbiosis. Though the systemic inflammation hypothesis starts to link gut dysbiosis to decompensated cirrhosis from a clinical perspective, a clearer demonstration is still needed for the role of the gut-liver-immune axis in cirrhosis progression. This review discusses the different immune states of the gut-liver axis in both healthy and cirrhotic settings and, more importantly, summarizes the current evidence about how microbiota-derived immune remodeling contributes to the progression of hepatic cirrhosis via the gut-liver axis.
引用
收藏
页数:13
相关论文
共 116 条
[1]   Cirrhosis-associated immune dysfunction [J].
Albillos, Agustin ;
Martin-Mateos, Rosa ;
van der Merwe, Schalk ;
Wiest, Reiner ;
Jalan, Rajiv ;
Alvarez-Mon, Melchor .
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2022, 19 (02) :112-134
[2]   The gut-liver axis in liver disease: Pathophysiological basis for therapy [J].
Albillos, Agustin ;
de Gottardi, Andrea ;
Rescigno, Maria .
JOURNAL OF HEPATOLOGY, 2020, 72 (03) :558-577
[3]   Hepatocyte mitochondria-derived danger signals directly activate hepatic stellate cells and drive progression of liver fibrosis [J].
An, Ping ;
Wei, Lin-Lin ;
Zhao, Shuangshuang ;
Sverdlov, Deanna Y. ;
Vaid, Kahini A. ;
Miyamoto, Makoto ;
Kuramitsu, Kaori ;
Lai, Michelle ;
Popov, Yury, V .
NATURE COMMUNICATIONS, 2020, 11 (01)
[4]   Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders [J].
Aron-Wisnewsky, Judith ;
Vigliotti, Chloe ;
Witjes, Julia ;
Le, Phuong ;
Holleboom, Adriaan G. ;
Verheij, Joanne ;
Nieuwdorp, Max ;
Clement, Karine .
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2020, 17 (05) :279-297
[5]   The systemic inflammation hypothesis: Towards a new paradigm of acute decompensation and multiorgan failure in cirrhosis [J].
Arroyo, Vicente ;
Angeli, Paolo ;
Moreau, Richard ;
Jalan, Rajiv ;
Claria, Joan ;
Trebicka, Jonel ;
Fernandez, Javier ;
Gustot, Thierry ;
Caraceni, Paolo ;
Bernardi, Mauro .
JOURNAL OF HEPATOLOGY, 2021, 74 (03) :670-685
[6]   Altered intestinal tight junctions' expression in patients with liver cirrhosis: a pathogenetic mechanism of intestinal hyperpermeability [J].
Assimakopoulos, Stelios F. ;
Tsamandas, Athanassios C. ;
Tsiaoussis, Georgios I. ;
Karatza, Elli ;
Triantos, Christos ;
Vagianos, Constantine E. ;
Spiliopoulou, Iris ;
Kaltezioti, Valeria ;
Charonis, Aristidis ;
Nikolopoulou, Vassiliki N. ;
Scopa, Chrisoula D. ;
Thomopoulos, Konstantinos C. .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2012, 42 (04) :439-446
[7]   Th17 Cell Induction by Adhesion of Microbes to Intestinal Epithelial Cells [J].
Atarashi, Koji ;
Tanoue, Takeshi ;
Ando, Minoru ;
Kamada, Nobuhiko ;
Nagano, Yuji ;
Narushima, Seiko ;
Suda, Wataru ;
Imaoka, Akemi ;
Setoyama, Hiromi ;
Nagamori, Takashi ;
Ishikawa, Eiji ;
Shima, Tatsuichiro ;
Hara, Taeko ;
Kado, Shoichi ;
Jinnohara, Toshi ;
Ohno, Hiroshi ;
Kondo, Takashi ;
Toyooka, Kiminori ;
Watanabe, Eiichiro ;
Yokoyama, Shin-ichiro ;
Tokoro, Shunji ;
Mori, Hiroshi ;
Noguchi, Yurika ;
Morita, Hidetoshi ;
Ivanov, Ivaylo I. ;
Sugiyama, Tsuyoshi ;
Nunez, Gabriel ;
Camp, J. Gray ;
Hattori, Masahira ;
Umesaki, Yoshinori ;
Honda, Kenya .
CELL, 2015, 163 (02) :367-380
[8]   The Evolving Challenge of Infections in Cirrhosis [J].
Bajaj, Jasmohan S. ;
Kamath, Patrick S. ;
Reddy, K. Rajender .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (24) :2317-2330
[9]  
Bajaj JS, 2020, J HEPATOL, V72, P1003, DOI 10.1016/j.jhep.2020.01.017
[10]   Long-term Outcomes of Fecal Microbiota Transplantation in Patients With Cirrhosis [J].
Bajaj, Jasmohan S. ;
Fagan, Andrew ;
Gavis, Edith A. ;
Kassam, Zain ;
Sikaroodi, Masoumeh ;
Gillevet, Patrick M. .
GASTROENTEROLOGY, 2019, 156 (06) :1921-+